Michael L. Kranda - Chief Executive Officer, Director @ Lifesprout

Overview

CB Rank (Investor)

Michael L. Kranda is the CEO and Board Member, LifeSprout. Michael L. Kranda attended at University of Washington.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Raven Biotechnologies	Vulcan Capital	Yes	Series D - Raven Biotechnologies	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

has

current jobs as

Chief Executive Officer, Director

and

SVP CNS Practice Lead

. Additionally,

has had

past jobs including

CEO

Organization Name	Title At Company	Start Date	End Date
BEAT BioTherapeutics	CEO	2013	2018
Vaccinogen	President and CEO	2010	2012
Vulcan Capital	Managing Director	Jan 2002	Jan 2007
Vulcan Capital	Managing Director of biotechnology venture investments	Sep 2003	Sep 2006
Oxford GlycoSciences	Chief Executive Officer	Jul 1996	Jul 2002
TwinStrand Biosciences	CEO	—	—
Immunet Corporation	President and Chief Operating Officer	—	—

Number of Past Board & Advisor Roles

Organization Name	Title At Company	Start Date	End Date
PTC Therapeutics	Member of the Board of Directors	2003	2015

Hub Name	CB Rank (Hub)
Catalio Capital Management Portfolio Companies	74,165
Emergency Medicine Companies With More Than $1M in Revenue	29,090
Camden Partners Portfolio Companies	84,582
Kairos Ventures Portfolio Companies	77,327
Medical Early Stage Companies With Fewer Than 50 Employees	36,933
United States Emergency Medicine Companies	9,109
Medical Early Stage Companies With More Than $1M in Revenue	42,109
Redmile Group Portfolio Companies	83,633
United States Medical Companies with Early Stage Venture Funding	47,103
Medical Early Stage Companies With Less Than $10M in Revenue	41,465